ReviewJournal of neural transmission (Vienna, Austria : 1996)2025
Update on sleep disorders in advanced Parkinson's disease: a narrative review.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple types of sleep disorders are encountered in patients with Parkinson's disease (PD) and are often underreported and underdiagnosed. They include circadian disorders, insomnia, excessive daytime sleepiness, rapid-eye-movement-sleep behavioral disorder, restless legs syndrome, and obstructive sleep apnea. The prevalence of sleep problems increases early in the disease course, and sleep quality deteriorates overall as patients age and the disease progresses. At advanced stages of PD, there is a reciprocal link between sleep problems and PD manifestations: sleep problems tend to exacerbate motor and non-motor symptoms, while worsening of motor and non-motor conditions have a detrimental effect on sleep quality. As the disease advances, sleep disorders have a growing negative influence on the quality of life of both patients and family caregivers. The causes of sleep disorders in this setting are neurodegeneration of key brain structures involved in sleep, motor and non-motor manifestations interfering with sleep, and drugs interfering with sleep. Treatment can include optimisation of antiparkinsonian treatment, reduction or removal of drugs interfering with sleep, treatment of non-motor manifestations interfering with sleep, pharmacological treatment of specific sleep disorders, and non-pharmacological approaches. Efforts should be made to raise awareness among patients, families, students, physicians, charities, funders, and policy makers regarding the prevalence and consequences of sleep disorders in advanced PD.
Indexed as
Identifiers
40748358What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.